Pages that link to "Q38096056"
Jump to navigation
Jump to search
The following pages link to Adjuvant immunotherapies as a novel approach to bacterial infections (Q38096056):
Displaying 7 items.
- ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo (Q36951826) (← links)
- Immunotherapy for Infectious Diseases: Past, Present, and Future (Q38635405) (← links)
- Canonical pathways, networks and transcriptional factor regulation by clinical strains of Mycobacterium tuberculosis in pulmonary alveolar epithelial cells (Q38786020) (← links)
- Pyrimidine synthesis inhibition enhances cutaneous defenses against antibiotic resistant bacteria through activation of NOD2 signaling. (Q54976744) (← links)
- Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines (Q58587624) (← links)
- Translating 'big data': better understanding of host-pathogen interactions to control bacterial foodborne pathogens in poultry (Q92451787) (← links)
- Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells (Q98205073) (← links)